BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 2,821–2,880 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

alternative treatment options1ambulatory oxygen therapy1amyloid-clearing therapies1anaesthetics1analgesic strategies1androgen receptor inhibitors1aneurysm embolization1angioplasty and stenting1angiotensin II receptor blocker1anteroseptal line ablation1anthracycline-based therapy1anti- H.pylori treatment1anti-CD19 CAR-T therapy1anti-CD20 therapies1anti-CGRP therapies1anti-CTLA4 therapy1anti-HER2 therapies1anti-HER2 therapy1anti-IL5R therapy1anti-PD therapy1anti-PD-(L)1 therapy1anti-PD-1 therapies1anti-PD-1/PD-L1 therapies1anti-TB therapy1anti-TNF treatment1anti-TNF-α therapy1anti-TNFα treatment1anti-aTNF therapy1anti-amyloid immunotherapy1anti-amyloid monoclonal antibody therapies1anti-cancer interventions1anti-cancer treatments1anti-eosinophilic biologic therapy1anti-fibrinolytic treatment1anti-fungal induction therapy1anti-hypertensives1anti-infective therapy1anti-infective treatment1anti-inflammation1anti-inflammatory analgesia1anti-inflammatory diet1anti-inflammatory strategies1anti-inflammatory-based management1anti-interleukin-1 therapy1anti-metabolite therapy1anti-metastatic therapies1anti-osteoporotic medication1anti-programmed cell death ligand-1(PD-L1) therapy1anti-programmed cell death protein 1 (PD-1) therapy1anti-programmed cell death protein 1 ICB1anti-programmed cell death protein 1 immunotherapy1anti-programmed cell death protein-1 (PD-1) therapy1anti-programmed cell death-ligand 1 immunotherapy1anti-programmed death-ligand 1 therapy1anti-pyretics1anti-reflux therapy1anti-rejection medication1anti-rejection medications1anti-respiratory syncytial virus (RSV) antibody prophylaxis1anti-rheumatic therapy1

Articles mentioning treatments

7,227 articles · page 117 of 603
immunosuppressantsCLA-IGA-RCutaneous lupus erythematosusantimalarialsBiogentopical corticosteroidssystemic lupus erythematosusCLEErythema

…ded antimalarials (69.7%), topical corticosteroids (50.8%), and immunosuppressants (37.7%). The majority were overweight or obese; most had never …

Antiresorptive or anabolic therapydenosumabosteoporosisteriperatidesystemic lupus erythematosusSLEtertiary hospital

… condition, and 17.5% were taking other osteopenic medications. Antiresorptive or anabolic therapy in SLE patients was independently associated with longer diseas…

autologous CD19-targeted CAR-T cell therapychimeric antigen receptor T (CAR-T) cell therapymitoxantrone-based reinduction chemotherapyblinatumomabB-cell acute lymphoblastic leukemiaB-ALL

…with relapsed B-ALL after blinatumomab who failed to respond to autologous CD19-targeted CAR-T cell therapy and mitoxantrone-based reinduction chemotherapy. The patient ac…

Intra-arterial chemotherapy for bleeding head and neck tumors: a single-center experience

neurintsurg · abstract · 2026-02-16 · 3 matching annotations

85.5%
intra-arterial (IA) chemotherapyembolizationcisplatincarboplatinoropharyngeal squamous cell carcinomasinonasal undifferentiated carcinomaAdvanced-stage head and neck cancersadvanced head and neck cancers

…apeutic interventions. In cases of tumor-associated hemorrhage, intra-arterial (IA) chemotherapy combined with embolization offers a potential treatment strateg…